Time to diagnosis and breast cancer stage by race/ethnicity.
Breast Cancer Res. Treat., Dec;136(3):813-21 (2012)
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.
J Natl Compr Canc Netw., Jul;10(7):821-9 (2012)
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.
PLoS ONE., 7(6):e38783 (2012)
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
Cancer., Dec;118(24):6022-30 (2012)
Clustering of place of birth for women with breast cancer: differences by tumor characteristics.
Cancer Causes Control., May (2012)
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
J. Clin. Oncol., Jun;30(18):2218-26 (2012)
The effect of age on delay in diagnosis and stage of breast cancer.
Oncologist., 17(6):775-82 (2012)
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
Cancer., Nov;118(22):5463-72 (2012)
True patriotism: a generation of commitment to quality in the Veterans Health Administration.
J. Clin. Oncol., Apr;30(10):1027-9 (2012)
Breast education in general surgery residency.
Am Surg., Jan;78(1):42-5 (2012)
Exploring the first days of adjustment to cancer: a modification of acclimating to breast cancer theory.
Cancer Nurs., 35(1):3-18 (2012 Jan-Feb)
Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics.
J. Nutr., Jan;142(1):91-8 (2012)
Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis.
Cancer Epidemiol. Biomarkers Prev., Jan;21(1):239-42 (2012)
Promoter methylation of E-cadherin, p16, and RAR-Î²(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism.
Nutr Cancer., 63(7):1143-50 (2011)
Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.
Am. J. Clin. Nutr., Sep;94(3):831-8 (2011)
Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
Ann. Surg., Aug;254(2):339-45 (2011)
Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
BMC Cancer., 11:278 (2011)
Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study.
Carcinogenesis., Aug;32(8):1223-30 (2011)
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
Cancer Causes Control., Jul;22(7):965-75 (2011)
Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?
Oncologist., 16(5):559-65 (2011)